Substance Use Disorders Practice Questions

Q: Which medication is used for smoking cessation?

Bupropion. **Explanation:** **Bupropion** is an atypical antidepressant that acts as a **Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)**. It is FDA-approved for smoking cessation because it mimics the effects of nicotine by increasing dopamine levels in the nucleus accumbens (the brain's reward center), thereby reducing withdrawal symptoms and the urge to smoke. **Analysis of Options:** * **A. Buspirone:** An anxiolytic and partial agonist at 5-HT1A receptors. It is used for Generalized Anxiety Disorder (GAD) but has no proven efficacy in smoking cessation. * **C. Methadone:** A long-acting mu-opioid receptor agonist used primarily for the detoxification and maintenance treatment of **Opioid Use Disorder**, not nicotine addiction. * **D. Venlafaxine:** A Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) used for depression and anxiety disorders. It is not a first-line agent for smoking cessation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Varenicline** (a nicotinic acetylcholine receptor partial agonist) is currently considered the **most effective** monotherapy for smoking cessation, followed by Bupropion and Nicotine Replacement Therapy (NRT). 2. **Contraindication:** Bupropion is strictly contraindicated in patients with **Seizure Disorders** or **Eating Disorders** (Bulimia/Anorexia) as it lowers the seizure threshold. 3. **Timing:** Treatment with Bupropion should ideally start **1–2 weeks before** the patient's "quit date" to reach steady-state plasma levels. 4. **Weight Gain:** Bupropion is often preferred for patients concerned about post-cessation weight gain, as it tends to delay this effect.

Q: Which of the following is a true statement about Korsakoff's psychosis?

Severe antegrade and mild retrograde memory defect. **Korsakoff’s Psychosis** (or Korsakoff’s Syndrome) is a chronic neuropsychiatric condition resulting from a deficiency of **Thiamine (Vitamin B1)**, most commonly seen in chronic alcohol use disorder. It often follows an untreated episode of Wernicke’s Encephalopathy. ### **Explanation of the Correct Answer** The hallmark of Korsakoff’s psychosis is a profound **amnestic syndrome**. * **Severe Antegrade Amnesia:** This is the most prominent feature. Patients have a near-total inability to form new memories or learn new information. * **Mild/Moderate Retrograde Amnesia:** Patients also lose memories of events that occurred prior to the onset of the illness, though this is typically less severe than the antegrade defect and follows a temporal gradient (older memories are better preserved). ### **Why Other Options are Incorrect** * **Option B:** This reverses the clinical presentation. In Korsakoff’s, the inability to form *new* memories (antegrade) is much more debilitating than the loss of *old* ones (retrograde). * **Options C & D:** These are incorrect because the syndrome is characterized by a **dual defect**. It is rarely isolated to just one direction of memory loss. ### **NEET-PG High-Yield Clinical Pearls** 1. **Confabulation:** A classic feature where patients fill memory gaps with fabricated, often grandiose stories. This is a compensatory mechanism, not intentional lying. 2. **Neuroanatomy:** The primary lesions are found in the **Dorsomedial nucleus of the Thalamus** and the **Mammillary bodies**. 3. **Wernicke-Korsakoff Syndrome (WKS):** Wernicke’s is the acute, reversible phase (Triad: Ataxia, Ophthalmoplegia, Confusion), while Korsakoff’s is the chronic, largely irreversible phase. 4. **Treatment:** High-dose parenteral Thiamine. **Crucial Rule:** Always administer Thiamine *before* Glucose to avoid precipitating or worsening the condition.

Q: All of the following can be used to treat alcohol dependence except?

Flumazenil. **Explanation:** The goal of treating alcohol dependence is to maintain abstinence and prevent relapse. **Flumazenil (Option C)** is the correct answer because it is a competitive **GABA-A receptor antagonist** used specifically for the reversal of **Benzodiazepine overdose**. It has no established role in the long-term management of alcohol dependence. **Analysis of Options:** * **Naltrexone (Option A):** An opioid receptor antagonist that reduces the "reward" or euphoria associated with drinking by blocking endogenous opioid release. It is effective in reducing cravings and the frequency of heavy drinking. * **Acamprosate (Option B):** A NMDA receptor antagonist and GABA-A enhancer. It helps maintain abstinence by restoring the chemical balance in the brain (homeostasis) that is disrupted by chronic alcohol use. It is particularly useful in patients with liver disease as it is renally excreted. * **Disulfiram (Option D):** An aldehyde dehydrogenase inhibitor. It causes the accumulation of acetaldehyde if alcohol is consumed, leading to an unpleasant "Disulfiram-like reaction" (flushing, tachycardia, nausea). It acts as a psychological deterrent (aversion therapy). **NEET-PG High-Yield Pearls:** * **First-line drugs** for alcohol dependence: Naltrexone and Acamprosate. * **Disulfiram** is considered second-line due to compliance issues and safety profiles. * **Topiramate** and **Baclofen** are off-label options often tested as "newer agents" for alcohol dependence. * **Wernicke’s Encephalopathy:** Always give Thiamine (B1) *before* Glucose in alcoholic patients to prevent precipitating acute neurological symptoms.

Q: Wernicke's encephalopathy involves which of the following structures?

Mammillary body. **Explanation:** **Wernicke’s Encephalopathy (WE)** is an acute, reversible neurological emergency caused by **Thiamine (Vitamin B1) deficiency**, most commonly seen in chronic alcohol use disorder. Thiamine is a critical cofactor for glucose metabolism; its deficiency leads to focal metabolic failure and subsequent necrosis in specific brain regions. **Why the Mammillary Body is Correct:** The **mammillary bodies** (part of the limbic system) are the most characteristic and frequently involved structures in WE. On MRI, they often show atrophy, signal intensity changes, or petechial hemorrhages. Other commonly involved areas include the periaqueductal gray matter and the walls of the third ventricle. **Analysis of Incorrect Options:** * **B. Thalamus:** While the dorsomedial nucleus of the thalamus is often involved in WE, the mammillary body is the "classic" hallmark structure tested in exams. If both are present, mammillary bodies are the primary pathological site. * **C. Frontal Lobe:** Frontal lobe atrophy is seen in chronic alcohol consumption (alcoholic dementia), but it is not the primary site of acute pathology in Wernicke’s Encephalopathy. * **D. Arcuate Fasciculus:** This is a white matter tract connecting Broca’s and Wernicke’s areas. Damage here leads to **Conduction Aphasia**, not nutritional encephalopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Global Confusion, Ophthalmoplegia/Nystagmus, and Ataxia (**Mnemonic: CAN** – **C**onfusion, **A**taxia, **N**ystagmus). * **Korsakoff Psychosis:** If WE is untreated, it progresses to Korsakoff syndrome, characterized by **anterograde amnesia** and **confabulation**. * **Management Rule:** Always administer Thiamine **before** Glucose. Giving glucose first in a thiamine-deficient patient can precipitate or worsen WE by consuming the remaining thiamine stores.

Q: Who first synthesized LSD?

Albert Hofmann. **Explanation:** **Correct Answer: A. Albert Hofmann** LSD (Lysergic acid diethylamide) was first synthesized by the Swiss chemist **Albert Hofmann** in **1938** while researching ergot derivatives at Sandoz Laboratories. However, its hallucinogenic properties were only discovered five years later, in 1943, when Hofmann accidentally ingested a small amount (an event famously known as "Bicycle Day"). LSD is a potent psychedelic that acts primarily as a partial agonist at **5-HT2A receptors**. **Analysis of Incorrect Options:** * **B. Delay and Deniker:** These French psychiatrists are credited with discovering the antipsychotic effects of **Chlorpromazine** in 1952, marking the beginning of the psychopharmacological revolution. * **C. John F. Cade:** An Australian psychiatrist who discovered the mood-stabilizing effects of **Lithium** in 1949 for the treatment of mania. * **D. Egas Moniz:** A Portuguese neurologist who developed the **prefrontal leucotomy** (lobotomy) and cerebral angiography. He was awarded the Nobel Prize in 1949. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** LSD is a potent serotonin agonist (specifically 5-HT2A). * **Clinical Features:** Causes profound perceptual distortions (hallucinations), synesthesia (seeing sounds/hearing colors), and "bad trips" (panic/psychosis). * **Flashbacks:** Also known as **Hallucinogen Persisting Perception Disorder (HPPD)**, where the user re-experiences the effects of LSD weeks or years after the last use. * **Physical Signs:** Marked **Mydriasis** (dilated pupils), tachycardia, and tremors. It does *not* cause physical dependence or withdrawal symptoms.

Q: A 'bad trip' is a common term used to describe an adverse psychological reaction to a psychoactive drug. Which of the following substances is most famously associated with inducing a 'bad trip'?

Lysergic acid diethylamide (LSD). ### Explanation **1. Why LSD is the Correct Answer:** Lysergic acid diethylamide (LSD) is a potent **hallucinogen** that acts primarily as a partial agonist at **5-HT2A receptors**. A **'bad trip'** is a classic clinical manifestation of LSD toxicity, characterized by an acute panic reaction, terrifying hallucinations (often visual), distorted time perception, and a fear of "going crazy" or dying. While other drugs can cause adverse effects, the term 'bad trip' is historically and clinically synonymous with the intense, unpredictable psychological distress triggered by LSD. **2. Analysis of Incorrect Options:** * **Cannabis (Option A):** While high doses of cannabis can cause "toxic psychosis" or acute anxiety/paranoia, it is primarily classified as a cannabinoid with sedative-hypnotic and mildly hallucinogenic properties. The specific nomenclature of a 'bad trip' is less characteristic of cannabis than it is of potent serotonergic psychedelics. * **Both Cannabis and LSD (Option D):** Although both can cause adverse psychological reactions, LSD is the "prototypical" substance associated with this phenomenon in medical literature and psychiatric examinations. **3. NEET-PG High-Yield Clinical Pearls:** * **Management:** The first-line treatment for an LSD-induced 'bad trip' is **"talking down"** (reassurance in a calm, dark environment). If pharmacological intervention is needed, **Benzodiazepines** (e.g., Diazepam) are the drugs of choice. * **Flashbacks:** Also known as **Hallucinogen Persisting Perception Disorder (HPPD)**, these are spontaneous recurrences of the drug experience in the absence of recent use. * **Synesthesia:** A common LSD phenomenon where senses blend (e.g., "seeing sounds" or "hearing colors"). * **Pupillary Sign:** LSD intoxication typically presents with **Mydriasis** (dilated pupils), unlike opioids which cause miosis.

Q: Which of the following is NOT a feature of alcohol withdrawal?

Hypersomnolence. **Explanation:** Alcohol is a Central Nervous System (CNS) depressant that enhances GABAergic (inhibitory) activity and inhibits NMDA (excitatory) receptors. Chronic consumption leads to down-regulation of GABA receptors and up-regulation of NMDA receptors to maintain homeostasis. When alcohol is abruptly stopped, this results in **CNS hyperexcitability** (autonomic hyperactivity). **Why Hypersomnolence is the correct answer:** Hypersomnolence (excessive sleepiness) is a feature of **CNS depression**, not withdrawal. In alcohol withdrawal, the patient typically experiences **insomnia** and agitation due to the lack of GABAergic inhibition. Hypersomnolence is more commonly seen during acute alcohol intoxication or withdrawal from CNS stimulants (like cocaine or amphetamines). **Analysis of incorrect options:** * **Restlessness:** This is an early sign of autonomic hyperactivity, often accompanied by tremors, tachycardia, and anxiety. * **Epileptic Seizures:** Known as "rum fits," these typically occur 6–48 hours after the last drink. They are usually generalized tonic-clonic (GTLC) seizures. * **Hallucinations:** Alcoholic hallucinosis can occur within 12–24 hours. These are typically **visual** (though auditory can occur) and happen in a state of clear consciousness, unlike Delirium Tremens. **High-Yield Clinical Pearls for NEET-PG:** * **Delirium Tremens (DT):** The most severe form of withdrawal, occurring 48–92 hours after cessation. Key features: Clouding of consciousness, vivid hallucinations, and autonomic instability. * **Drug of Choice:** Benzodiazepines (e.g., Diazepam, Chlordiazepoxide) are the gold standard for managing withdrawal symptoms. * **Wernicke’s Encephalopathy:** Always give **Thiamine** before Glucose to prevent precipitating this condition.

Q: Which of the following is the most common cause of emergency department visits related to LSD and its related substances?

Bad trip. **Explanation:** **LSD (Lysergic Acid Diethylamide)** is a potent hallucinogen that acts primarily as a partial agonist at the **5-HT2A receptors**. **1. Why "Bad Trip" is correct:** The most frequent reason for emergency department (ED) visits following LSD ingestion is an acute adverse psychological reaction, commonly known as a **"Bad Trip."** This is characterized by intense anxiety, terrifying hallucinations, panic attacks, and a loss of control. Patients often present with "behavioral toxicity," where their distorted perception leads to agitation or dangerous behavior, necessitating medical intervention (usually with benzodiazepines). **2. Analysis of Incorrect Options:** * **Flashbacks (Hallucinogen Persisting Perception Disorder):** These are spontaneous recurrences of the sensory distortions experienced during a previous trip. While distressing, they are usually brief and less likely to result in an acute ED visit compared to an active bad trip. * **Synaesthesia:** This is a classic effect of LSD where senses "merge" (e.g., "hearing colors" or "seeing sounds"). It is a subjective pharmacological effect rather than a medical emergency. * **Pupillary Dilatation (Mydriasis):** This is a common physical sign of LSD use due to sympathetic stimulation. While clinically observable, it is an expected physiological effect and not a reason for emergency presentation. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** 5-HT2A receptor agonism. * **Physical Signs:** Mydriasis, tachycardia, tremors, and hyperreflexia. * **Tolerance:** Develops very rapidly (tachyphylaxis) but there is no physical dependence or withdrawal syndrome. * **Management:** Most LSD-related ED visits are managed with a "calm down" technique in a quiet room; severe agitation is treated with **Benzodiazepines**. Antipsychotics (like Haloperidol) should be used with caution as they can lower the seizure threshold.

Question 1

Which medication is used for smoking cessation?

Accepted Answer

Bupropion

Answer

Buspirone

Answer

Methadone

Answer

Venlafaxine

Question 2

Which of the following is a true statement about Korsakoff's psychosis?

Accepted Answer

Severe antegrade and mild retrograde memory defect

Answer

Mild antegrade and severe retrograde memory defect

Answer

Only antegrade memory defect

Answer

Only retrograde memory defect

Question 3

All of the following can be used to treat alcohol dependence except?

Accepted Answer

Flumazenil

Answer

Naltrexone

Answer

Acamprosate

Answer

Disulfiram

Question 4

No treatment of withdrawal is required in which of the following?

Accepted Answer

LSD

Answer

Opium

Answer

Alcohol

Answer

Amphetamine

Question 5

Wernicke's encephalopathy involves which of the following structures?

Accepted Answer

Mammillary body

Answer

Thalamus

Answer

Frontal lobe

Answer

Arcuate fasciculus

Question 6

Who first synthesized LSD?

Accepted Answer

Albert Hofmann

Answer

Delay and Deniker

Answer

John F. Cade

Answer

Egas Moniz

Question 7

A 'bad trip' is a common term used to describe an adverse psychological reaction to a psychoactive drug. Which of the following substances is most famously associated with inducing a 'bad trip'?

Accepted Answer

Lysergic acid diethylamide (LSD)

Answer

Cannabis

Answer

None of the above

Answer

Both Cannabis and Lysergic acid diethylamide (LSD)

Question 8

Which of the following is NOT a feature of alcohol withdrawal?

Accepted Answer

Hypersomnolence

Answer

Epileptic seizure

Answer

Restlessness

Answer

Hallucination

Question 9

Which of the following is the most common cause of emergency department visits related to LSD and its related substances?

Accepted Answer

Bad trip

Answer

Flashbacks

Answer

Synaesthesia

Answer

Papillary dilatation

Question 10

Alcohol dependence is seen in which of the following psychosexual stages?

Accepted Answer

Oral phase

Answer

Phallic phase

Answer

Anal phase

Answer

Latency phase

Substance Use Disorders — MCQs

Substance Use Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?